BCR-JAK2 drives a myeloproliferative neoplasm in transplanted mice-Reference-Cited by-同舟云学术

BCR-JAK2 drives a myeloproliferative neoplasm in transplanted mice

Published:2015-03-03 Issue:2 Volume:236 Page:219-228
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Cuesta-Domínguez Álvaro¹,León-Rico Diego²³,Álvarez Lara²³,Díez Begoña²³,Bodega-Mayor Irene¹,Baños Rocío²³,Martín-Rey Miguel Ángel²³,Santos-Roncero Matilde¹,Gaspar María Luisa⁴,Martín-Acosta Paloma⁵,Almarza Elena²³,Bueren Juan A.²³,Río Paula²³,Fernández-Ruiz Elena¹

Affiliation:

1. Molecular Biology Unit; Instituto de Investigación Sanitaria Princesa (IIS-P, UAM), Hospital Universitario de La Princesa; Madrid Spain

2. Division of Haematopoietic Innovative Therapies; CIEMAT/CIBERER; Madrid Spain

3. Instituto de Investigaciones Sanitarias Fundación Jiménez Díaz (IIS-FJD, UAM); Madrid Spain

4. Centro Nacional de Microbiología; Instituto de Salud Carlos III (ISCIII); Majadahonda Spain

5. Servicio de Anatomía Patológica; Hospital Universitario Puerta de Hierro; Majadahonda Spain

Funder

Instituto de Salud Carlos III (FEDER)

Spanish Ministry of Economy and Competitiveness

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference52 articles.

1. Jak2: normal function and role in hematopoietic disorders;Ihle;Curr Opin Genet Dev,2007

2. Jak2 is essential for signaling through a variety of cytokine receptors;Parganas;Cell,1998

3. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis;Neubauer;Cell,1998

4. Selective deletion of Jak2 in adult mouse hematopoietic cells leads to lethal anemia and thrombocytopenia;Grisouard;Haematologica,2014

5. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses;Teglund;Cell,1998

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The First Case Report of JAK2–BCR–PPP1R32 Fusion Genes Because of a Translocation (9;22;11)(p24;q11.2;q13) in a Patient With Myeloproliferative Neoplasm;Annals of Laboratory Medicine;2022-12-22

2. Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1 ‐ JAK2 , BCR‐JAK2 and ETV6‐ABL1 fusion genes;American Journal of Hematology;2020-04-28

3. BCR–JAK2 fusion in a myeloproliferative neoplasm with associated eosinophilia;Cancer Genetics;2016-05